[Metabolic determinants of efficacy of infrared laser therapy in hypertensive patients with combined pathology].
By a distinct pathogenetic direction of a therapeutic action of laser therapy (LT) on different regulators of blood pressure (BP) and metabolism, 109 patients with essential hypertension (EH) and atherosclerosis and/or diabetes mellitus were studied for LT efficacy depending on metabolis disorders. LT demonstrated metabolic neutrality and unefficacy in patients with multiple marked disorders of fat metabolism and hyperglycemia. Metabolic factors determining LT efficacy comprise hypercholesterinemia, hypertriglyceridemia and hyperglycemia. The factorial analysis points to essential factor restructuring in metabolic disorders. The obtained equation of multiple regression allows prognostication of the degree of a fall of mean BP in response to LT depending on the degree of metabolic disorders.
Krysiuk
O B
OB
Ponomarenko
G N
GN
Obrezan
A G
AG
Kostin
N A
NA
D000328:Adult; D001161:Arteriosclerosis / Q000150:complications / Q000532:radiotherapy; D015415:Biomarkers / Q000097:blood / Q000378:metabolism; D001786:Blood Glucose / Q000032:analysis; D001794:Blood Pressure / Q000528:radiation effects; D002784:Cholesterol / Q000097:blood; D003920:Diabetes Mellitus / Q000532:radiotherapy; D005260:Female; D005947:Glucose / Q000378:metabolism; D006801:Humans; D006973:Hypertension / Q000150:complications / Q000378:metabolism / Q000532:radiotherapy*; D007259:Infrared Rays / Q000627:therapeutic use*; D053685:Laser Therapy; D008297:Male; D008875:Middle Aged; D016896:Treatment Outcome
D015415:Biomarkers; D001786:Blood Glucose; D002784:Cholesterol; D005947:Glucose